162 related articles for article (PubMed ID: 30925116)
21. Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
Zhu H; Cao J; Cui S; Qian Z; Gu Y
J Pharm Sci; 2013 Apr; 102(4):1318-32. PubMed ID: 23400693
[TBL] [Abstract][Full Text] [Related]
22. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937
[TBL] [Abstract][Full Text] [Related]
23. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
24. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting.
Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z
Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739
[TBL] [Abstract][Full Text] [Related]
25. Effects of nanoparticle size on antitumor activity of 10-hydroxycamptothecin-conjugated gold nanoparticles: in vitro and in vivo studies.
Bao H; Zhang Q; Xu H; Yan Z
Int J Nanomedicine; 2016; 11():929-40. PubMed ID: 27022260
[TBL] [Abstract][Full Text] [Related]
26. Preparation and pharmacodynamics of stearic acid and poly (lactic-co-glycolic acid) grafted chitosan oligosaccharide micelles for 10-hydroxycamptothecin.
Zhou YY; Du YZ; Wang L; Yuan H; Zhou JP; Hu FQ
Int J Pharm; 2010 Jun; 393(1-2):143-51. PubMed ID: 20420886
[TBL] [Abstract][Full Text] [Related]
27. [Antitumor effects of ring-closed and ring-opened hydroxycamptothecin on oral squamous carcinoma cell line Tca8113].
Wang AX; Li S; Ding XQ; Chen Y; Chen D
Ai Zheng; 2005 Aug; 24(8):970-4. PubMed ID: 16086875
[TBL] [Abstract][Full Text] [Related]
28. Hydroxycamptothecin liposomes based on thermal and magnetic dual-responsive system: preparation, in vitro and in vivo antitumor activity, microdialysis-based tumor pharmacokinetics.
Zhu HM; Gu JH; Xie Y; Xie B; Ling JJ
J Drug Target; 2018 Apr; 26(4):345-356. PubMed ID: 28920483
[TBL] [Abstract][Full Text] [Related]
29. Preparation and
Zhou T; Tang X; Zhang W; Feng J; Wu W
Drug Deliv; 2019 Dec; 26(1):673-679. PubMed ID: 31266376
[TBL] [Abstract][Full Text] [Related]
30. Hydroxycamptothecin (HCPT)-loaded PEGlated lipid-polymer hybrid nanoparticles for effective delivery of HCPT: QbD-based development and evaluation.
Ma Z; Liu J; Li X; Xu Y; Liu D; He H; Wang Y; Tang X
Drug Deliv Transl Res; 2022 Jan; 12(1):306-324. PubMed ID: 33712991
[TBL] [Abstract][Full Text] [Related]
31. [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice].
Zhang XX; Gan Y; Yang XG; Zhu CL; Gan L; Nie SF; Pan WS
Yao Xue Xue Bao; 2008 Jan; 43(1):91-6. PubMed ID: 18357740
[TBL] [Abstract][Full Text] [Related]
32. [Preparation and characterization of hydroxycamptothecin nanoparticles of amphiphilic block copolymer].
Xi N; Hou LB
Zhong Yao Cai; 2009 Apr; 32(4):604-7. PubMed ID: 19645250
[TBL] [Abstract][Full Text] [Related]
33. Dual-drug loaded nanoneedles with targeting property for efficient cancer therapy.
Yang X; Wu S; Xie W; Cheng A; Yang L; Hou Z; Jin X
J Nanobiotechnology; 2017 Dec; 15(1):91. PubMed ID: 29258613
[TBL] [Abstract][Full Text] [Related]
34. In-vivo pharmacokinetics, tissue distribution and anti-tumour effect of hydroxycamptothecin delivered in oil-in-water submicron emulsions.
Zhao YX; Liu DX; Liang WQ; Ye ZW
J Pharm Pharmacol; 2012 Jun; 64(6):783-91. PubMed ID: 22571256
[TBL] [Abstract][Full Text] [Related]
35. Antimetastasis and antitumor efficacy promoted by sequential release of vascular disrupting and chemotherapeutic agents from electrospun fibers.
Luo X; Zhang H; Chen M; Wei J; Zhang Y; Li X
Int J Pharm; 2014 Nov; 475(1-2):438-49. PubMed ID: 25218185
[TBL] [Abstract][Full Text] [Related]
36. Enhanced nuclear delivery and cytotoxic activity of hydroxycamptothecin using o/w emulsions.
Zhao Y; Gao J; Sun X; Chen H; Wu L; Liang W
J Pharm Pharm Sci; 2007; 10(1):61-70. PubMed ID: 17498395
[TBL] [Abstract][Full Text] [Related]
37. Preparation and properties of hydroxycamptothecin-loaded nanoparticles made of amphiphilic copolymer and normal polymer.
Wang J; Wang R; Li LB
J Colloid Interface Sci; 2009 Aug; 336(2):808-13. PubMed ID: 19520376
[TBL] [Abstract][Full Text] [Related]
38. 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice.
Zhang L; Yang M; Wang Q; Li Y; Guo R; Jiang X; Yang C; Liu B
J Control Release; 2007 Jun; 119(2):153-62. PubMed ID: 17400320
[TBL] [Abstract][Full Text] [Related]
39. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
[TBL] [Abstract][Full Text] [Related]
40. PEG-chitosan-coated iron oxide nanoparticles with high saturated magnetization as carriers of 10-hydroxycamptothecin: preparation, characterization and cytotoxicity studies.
Qu JB; Shao HH; Jing GL; Huang F
Colloids Surf B Biointerfaces; 2013 Feb; 102():37-44. PubMed ID: 23000675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
